TITLE

Lateral epikondilit tedavisinde otolog trombositten zengin plazmanın etkisi

AUTHOR(S)
Ağır, İsmail; Çaypınar, Barış; Topkar, Osman Mert; Karahan, Mustafa
PUB. DATE
March 2011
SOURCE
Dicle Medical Journal / Dicle Tip Dergisi;2011, Vol. 38 Issue 1, p40
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Lateral epicondylitis (tennis elbow) is the most commonly diagnosed cause of lateral elbow pain. The aim of this study was to compare the effect of single dose corticosteroid and autologous platelet rich plasma (PRP) injection in the treatment of tennis elbow. Materials and methods: The 15 elbow of 15 patients (6 male and 9 female) was included in the study, who applied to our clinic with lateral elbow pain and diagnosed as lateral epicondylitis. A single dose of 0,5 ml Bethametasone and 0,5 ml Prilocaine mixture was applied to first group and single dose 1 ml autologous PRP was locally applied to the second group. Results: In the early follow-ups the results of corticosteroid group were better than latter follow-ups, however in PRP group the results were worst in early follow-ups but better results were obtained in later follow-ups according to Verhaar scoring system. Conclusion: According to our results, the beneficial effects of PRP injection in lateral epicondylitis increases over time but further studies with more patients and longer follow up durations should done in order to more clarified this subject.
ACCESSION #
59310922

 

Related Articles

  • Effect of Corticosteroid Injection, Physiotherapy, or Both on Clinical Outcomes in Patients With Unilateral Lateral Epicondylalgia. Coombes, Brooke K.; Bisset, Leanne; Brooks, Peter; Khan, Asad; Vicenzino, Bill // JAMA: Journal of the American Medical Association;2/6/2013, Vol. 309 Issue 5, p461 

    The article offers information on the randomized controlled trial conducted to evaluate the effectiveness of corticosteroid injection and multimodal physiotherapy or both in patients suffering from unilateral lateral epicondylalgia. It mentions that the factorial randomized injection-blinded...

  • Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients. Peñalver, Francisco; Jiménez-Yuste, Victor; Almagro, Manuel; Alvarez-Larrán, Alberto; Rodríguez, Lluis; Casado, Marisol; Gallur, Laura; Giraldo, Pilar; Hernández, Roberto; Menor, Dolores; Rodríguez, Maria; Caballero, Dolores; González, Raúl; Mayans, José; Millán, Isabel; Cabrera, José // Annals of Hematology;Jun2006, Vol. 85 Issue 6, p400 

    Rituximab induces B-cell depletion; therefore, it has been used in the treatment of immune thrombocytopenic purpura (ITP). The aim of this retrospective study was to evaluate the effectiveness of rituximab in the treatment of 89 patients with chronic ITP refractory to several treatments. All the...

  • Effect of betametasone administration on platelet count in thrombocytopenic and normal pregnant women. Giannubilo, Stefano; Shkara, Vissam; Tranquilli, Andrea // Archives of Gynecology & Obstetrics;Jun2006, Vol. 274 Issue 3, p130 

    Objective: To evaluate the effect of a course of corticosteroids on platelet count in both thrombocytopenic and normal pregnant women. Study design: We retrospectively considered 107 pregnant women at 24–34 weeks gestation, who had received betametasone treatment (12 mg i.m. for two...

  • Does treatment of newly diagnosed idiopathic thromboctypenic purpura reduce morbidity? Treutiger, Iris; Rajantie, Jukka; Zeller, Bernward; Henter, Jan-Inge; Elinder, Göron; Rosthøj, Steen // Archives of Disease in Childhood;Aug2007, Vol. 92 Issue 8, p704 

    Aim: To explore whether early treatment of children with idiopathic thrombocytopenic purpura (IIP) with immunoglobulin and/or corticosteroids reduces subsequent morbidity. Methods: Centres participating in a Nordic lip study were divided according to whether they had treated more than 2/3, from...

  • MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy. Phan-Ba, Rémy; Lommers, Emilie; Tshibanda, Luaba; Calay, Philippe; Dubois, Bernard; Moonen, Gustave; Clifford, David; Belachew, Shibeshih // Journal of Neurology, Neurosurgery & Psychiatry;Feb2012, Vol. 83 Issue 2, p224 

    Early detection of progressive multifocal leucoencephalopathy (PML) in the setting of natalizumab therapy currently is performed by rapid evaluation of new symptoms occurring in treated patients. The role of MR scanning has not been investigated but holds promise since MR detection is highly...

  • TRATAMENTUL CU TERAPII DERIVATE DIN PLASMÄ‚ UMANÄ‚ (IMUNOGLOBULINE POLIVALENTE PE CALE INTRAVENOASÄ‚ ÅžI IMUNOBLOBULINA ANTI-D) ÃŽN PURPURA TROMBOCITOPENICÄ‚ IDIOPATICÄ‚ (PTI) ACUTÄ‚ LA COPIL. Stan, Olimpiu; Miculschi, Gabriela; Ioniţă, Hortensia // Clujul Medical;Sep2010, Vol. 83 Issue 3, p421 

    For more than two decades intravenous immunoglobulins (IVIG) have benefited patients with autoimmune diseases. Immune globuline is prepared from pooled plasma from healthy blood donors. Many authors recommend IVIG, high doses of corticosteroids, or anti-D to treat the children with acute ITP at...

  • An experimental study of the effect of autologous platelet rich plasma on the healing process of tendon in donkeys. Aljobory, A. Kh. // Iraqi Journal of Veterinary Sciences;2009, Vol. 23 Issue 3, p81 

    The aim of this study was to evaluate the regenerative effect of platelets rich plasma PRP on tendon healing in donkeys. Eight adult donkeys from both sexes were used. The age range from 2-4 years and weighting 150-180 kg. The animals divided into two groups control and treatment group each...

  • Blood Components for Hemostasis. Eldin, Karen W.; Teruya, Jun // Laboratory Medicine;Fall2012, Vol. 43 Issue 6, p237 

    We present an overview of revised indications and doses for routinely transfused blood components. Targeted blood component therapy is one of the earliest models of personalized medicine, striving to achieve the tenets of the right dose at the right time for the right reason to the right...

  • Current concepts in platelet transfusion. Mohanty, Dipika // Asian Journal of Transfusion Science;Jan-Jun2009, Vol. 3 Issue 1, p18 

    This is the era of component therapy. Therefore there is a need for rational use of platelet concentrate. Lot of knowledge has been added recently in the field of platelet specially about the platelet rich plasma and its application in clinical practice. The current review focuses on improvement...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics